409 results on '"Grutters, JC"'
Search Results
2. Potential therapeutic targets to prevent organ damage in chronic pulmonary sarcoidosis
3. Poster session 2: Thursday 4 December 2014, 08: 30–12: 30Location: Poster area
4. Unbound Plasma, Total Plasma, and Whole-Blood Tacrolimus Pharmacokinetics Early After Thoracic Organ Transplantation
5. Patient expectations, experiences and satisfaction with nintedanib and pirfenidone in idiopathic pulmonary fibrosis: a quantitative study
6. Design of a randomized controlled trial to evaluate effectiveness of methotrexate versus prednisone as first-line treatment for pulmonary sarcoidosis: the PREDMETH study
7. THE CROSSED WIRING TECHNIQUE, ESPECIALLY THE PARASTERNAL TECHNIQUE, IS ASSOCIATED WITH LESS STERNAL DEHISCENCE AFTER BILATERAL LUNG TRANSPLANTATION: RO-238
8. Value of serum soluble interleukin-2 receptor as a diagnostic and predictive biomarker in sarcoidosis
9. Results of the standard set for pulmonary sarcoidosis: feasibility and multicentre outcomes
10. First patient-centred set of outcomes for pulmonary sarcoidosis: a multicentre initiative
11. Pharmacokinetics (PK) of nintedanib with add-on pirfenidone in patients with idiopathic pulmonary fibrosis (IPF): results from INJOURNEY
12. mTOR inhibitor-induced interstitial lung disease in cancer patients : Comprehensive review and a practical management algorithm
13. Chest Imaging
14. Clinical Cases: HIT session - Top of the hub: best clinical cases852A rare cause of severe chest pain and sustained ventricular tachycardia during a football game853Thrombosed iliac venous aneurysm as a extremely rare source of pulmonary thromboembolism8543D transesophageal echo: guide to anticoagulation therapy after surgical closure of the left atrial appendage855A unusual case of giant coronary aneurysm: role of multimodality imaging in the diagnosis and follow-up858Myocardial cleft in a patient with acute coronary syndrome assessed by multimodal imaging859A rare case of subacute left atrial dissection860A case of pulmonary sarcoidosis with severe precapillary pulmonary hypertension and extrinsic compression of the pulmonary artery
15. Discrepant elevation of sIL-2R levels in sarcoidosis patients with renal insufficiency
16. Non-specific and Usual Interstitial Pneumonia, Short-Term Survival After Surgical Biopsy
17. Is there evidence for anti-TNF drugs in joint involvement in sarcoidosis?
18. Idiopathic pulmonary fibrosis: new insights
19. Efficacy of adalimumab in sarcoidosis patients who developed intolerance to infliximab
20. Efficacy of adalimumab in sarcoidosis patients who developed intolerance to infliximab
21. mTOR inhibitor-induced interstitial lung disease in cancer patients: Comprehensive review and a practical management algorithm
22. Reconciling Healthcare Professional and Patient Perspectives in the Development of Disease Activity and Response Criteria in Connective Tissue Disease Related Interstitial Lung Diseases
23. Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: Provisional core sets of domains and instruments for use in clinical trials
24. Early Experience of Pirfenidone in Daily Clinical Practice in Belgium and The Netherlands : a Retrospective Cohort Analysis
25. Idiopathische pulmonale fibrose : nieuwe inzichten
26. New treatment strategies for pulmonary sarcoidosis : antimetabolites, biological drugs, and other treatment approaches
27. Understanding Idiopathic Interstitial Pneumonia : A Gene-Based Review of Stressed Lungs
28. Effectiveness of infliximab in refractory FDG PET-positive sarcoidosis
29. The importance of biobank and nationwide registry for lymphangioleiomyomatosis in a small sized country
30. Understanding Idiopathic Interstitial Pneumonia: A Gene-Based Review of Stressed Lungs
31. Is there evidence for anti-TNF drugs in joint involvement in sarcoidosis?
32. Idiopathische pulmonale fibrose: nieuwe inzichten
33. Chest Imaging
34. Discrepant elevation of sIL-2R levels in sarcoidosis patients with renal insufficiency
35. Non-specific and Usual Interstitial Pneumonia, Short-Term Survival After Surgical Biopsy
36. Early Experience of Pirfenidone in Daily Clinical Practice in Belgium and The Netherlands: a Retrospective Cohort Analysis
37. The importance of biobank and nationwide registry for lymphangioleiomyomatosis in a small sized country
38. New treatment strategies for pulmonary sarcoidosis: antimetabolites, biological drugs, and other treatment approaches
39. Effectiveness of infliximab in refractory FDG PET-positive sarcoidosis
40. Early Experience of Pirfenidone in Daily Clinical Practice in Belgium and The Netherlands: a Retrospective Cohort Analysis
41. The Occurrence of Hermansky Pudlak Syndrome in Patients with Idiopathic Pulmonary Fibrosis–A Cohort Study
42. Acknowledging Patient Heterogeneity in Economic Evaluation
43. European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis
44. Pneumoproteins as a lung-specific biomarker of alveolar permeability in conventional on-pump coronary artery bypass graft surgery vs mini-extracorporeal circuit - A pilot study
45. Primary endpoints in phase 3 clinical trials in idiopathic pulmonary fibrosis: One step at a time
46. Is the different T helper cell activity in sarcoidosis and extrinsic allergic alveolitis also reflected by the cellular bronchoalveolar lavage fluid profile?
47. Dexamethasone in community-acquired pneumonia – Authors' reply
48. Biomarkers define the clinical response to dexamethasone in community-acquired pneumonia.
49. Post-inflammatory fatigue in sarcoidosis: Personality profiles, psychological symptoms and stress hormones.
50. Transforming growth factor-beta gene polymorphisms in sarcoidosis patients with and without fibrosis.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.